EE285 Cost-Effectiveness of Evolocumab Versus Standard Therapy for the Treatment of Dyslipidemia in Patients with Cardiovascular Disease in Qatar von AlMukdad, S, Kaddoura, R, Arabi, AR, AlMaraghi, F, Al-Saadi Al Yafei, S, Al-Badriyeh, D

Volltext

EE431 Description of Clinical Pharmacists Reported Interventions to Prevent Adverse Drug Events Among Patients with Cardiovascular Disease von Abushanab, D, Mohammed, R, Kaddoura, R, AlMaraghi, F, Farhat, A, Mahfouz, A, Abdul, Rouf P, Elkassem, W, Al Hail, M, Al-Saadi Al Yafei, S, Al-Badriyeh, D

Volltext